Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors
Zhao, Qian, Manning, James R, Sutton, James, Costales, Abran, Sendzik, Martin, Shafer, Cynthia M., Levell, Julian R., Liu, Gang, Caferro, Thomas, Cho, Young Shin, Palermo, Mark, Chenail, Gregg, DooleyLanguage:
english
Journal:
ACS Medicinal Chemistry Letters
DOI:
10.1021/acsmedchemlett.8b00182
Date:
June, 2018
File:
PDF, 433 KB
english, 2018